Calithera Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Calithera Biosciences

16/08/2022 10:55

* Calithera Biosciences Inc  CALA.OQ  reported a quarterly
adjusted loss of $1.87​​ per share for the quarter ended in
June. The mean expectation of four analysts for the quarter was
for a loss of $2.65 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Calithera Biosciences Inc's reported EPS for the quarter
was a
loss of $1.87​.
    * The mean earnings estimate of analysts had risen by
about 5.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Calithera Biosciences Inc shares had risen by 68.1% this
quarter and lost 68.9% so far this year.
    * The company reported a quarterly loss of $9.08 million.
    * Wall Street's median 12-month price target for Calithera
Biosciences Inc is $30.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 16
at 09:55 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -2.65          -1.87          Beat
 Mar. 31 2022      -3.70          -3.60          Beat
 Dec. 31 2021      -4.80          -4.80          Met
 Sep. 30 2021      -4.56          -3.00          Beat